Cellmid limited mail
Cellmid Limited is an Australian biotechnology company that specializes in the development and commercialization of innovative diagnostic tests and biomarkers for various diseases. Here are some key points about Cellmid Limited:
Company Overview: Cellmid Limited is a publicly listed company on the Australian Securities Exchange (ASX) under the ticker code CDY. The company was founded in 2001 and is headquartered in Sydney, Australia.
Products and Services: Cellmid's primary focus is on the development of diagnostic tests and biomarkers for various diseases, including cancer, cardiovascular disease, and infectious diseases. The company's products and services include:
- Diagnostic tests: Cellmid develops and commercializes diagnostic tests for various diseases, including cancer, cardiovascular disease, and infectious diseases.
- Biomarkers: The company identifies and develops biomarkers for various diseases, which can be used to diagnose and monitor disease progression.
- Research and development: Cellmid conducts research and development activities to identify new biomarkers and develop new diagnostic tests.
Key Products: Some of Cellmid's key products and services include:
- Cellmid's flagship product is the Cellmid Cancer Test, which is a non-invasive diagnostic test for the detection of cancer biomarkers in blood.
- The company's CardioDx test is a diagnostic test for the detection of cardiovascular disease biomarkers in blood.
- Cellmid's Infectious Disease Test is a diagnostic test for the detection of infectious disease biomarkers in blood.
Partnerships and Collaborations: Cellmid has partnerships and collaborations with various organizations, including:
- Research institutions: The company collaborates with research institutions to identify new biomarkers and develop new diagnostic tests.
- Pharmaceutical companies: Cellmid partners with pharmaceutical companies to develop and commercialize new diagnostic tests and biomarkers.
- Healthcare providers: The company works with healthcare providers to develop and commercialize new diagnostic tests and biomarkers.
Financials: Cellmid Limited is a publicly listed company, and its financial performance is publicly disclosed. The company's revenue and profitability have been impacted by various factors, including the COVID-19 pandemic.
Contact Information: If you would like to contact Cellmid Limited, you can reach out to them through their website or through their investor relations department.